Movano(US:MOVE) Prnewswireยท2024-06-10 13:00Core Insights - MIT has partnered with Movano Health for the MAESTRO study, aiming to enhance understanding of long COVID and chronic Lyme disease through continuous health monitoring using Movano's Evie Ring [2][6][10] Company Overview - Movano Health, founded in 2018, focuses on developing healthcare solutions that provide medical-grade data through wearable devices, offering personalized health insights [11] - The Evie Ring is designed to meet HIPAA and cybersecurity standards, providing a reliable alternative to existing health monitoring devices [10] Study Details - The MAESTRO study will recruit 300 adults aged 18-35 from four cohorts: acute Lyme disease, chronic Lyme disease, long COVID, and a control group [6] - Approximately 40 million Americans are affected by long COVID, with over 600,000 new Lyme disease cases annually, 10-15% of which may develop into chronic Lyme disease [6] Research Significance - The collaboration is expected to provide valuable longitudinal data on vital signs and wellness, enhancing the understanding of long COVID and chronic Lyme disease [10] - The Tal Research Group, led by Dr. Michal Caspi Tal, specializes in chronic illness research and aims to bridge knowledge gaps in diagnostics and treatment for complex chronic conditions [10]